Ratings by UBS (Ashwani Verma)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/3/2026 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2026 | MapLight Therapeutics | MPLT | New Coverage | Buy (N/A) |
28.75 (30.65) |
6.61% | Details | |
| 5/19/2026 | Jazz Pharmaceuticals | JAZZ | Upgrade | Buy (Neutral) |
228.77 (229.85) |
0.47% | Details | |
| 5/13/2026 | Corcept Therapeutics | CORT | Upgrade | Neutral (N/A) |
51.20 (81.56) |
59.3% | Details | |
| 5/6/2026 | Alkermes | ALKS | Maintain | Buy (Buy) |
|
Details | ||
| 4/30/2026 | Incyte | INCY | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2026 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2026 | Amneal Pharmaceuticals | AMRX | New Coverage | Buy (N/A) |
13.05 (17.27) |
32.34% | Details | |
| 4/14/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2026 | Incyte | INCY | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/24/2026 | Alvotech SA | ALVO | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Cytokinetics | CYTK | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/5/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Viatris | VTRS | Maintain | Buy (Buy) |
|
Details | ||
| 2/24/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 2/17/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2026 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Neutral (Buy) |
37.93 (34.45) |
-9.17% | Details | |
| 2/9/2026 | Viatris | VTRS | Upgrade | Buy (Neutral) |
14.58 (15.93) |
9.26% | Details | |
| 1/30/2026 | Royalty Pharma | RPRX | Upgrade | Buy (Neutral) |
40.41 (54.28) |
34.32% | Details | |
| 1/28/2026 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2026 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 1/6/2026 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 1/5/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 12/29/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Corcept Therapeutics | CORT | New Coverage | Neutral (N/A) |
87.99 (51.20) |
-41.81% | Details | |
| 12/8/2025 | Legend Biotech Corp. | LEGN | Maintain | Buy (Buy) |
|
Details | ||
| 12/4/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 12/1/2025 | Cytokinetics | CYTK | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/26/2025 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Neutral (Buy) |
9.68 (14.96) |
54.55% | Details | |
| 11/24/2025 | Jazz Pharmaceuticals | JAZZ | Downgrade | Neutral (Buy) |
176.93 (228.77) |
29.3% | Details | |
| 11/6/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2025 | Exelixis | EXEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/31/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 10/28/2025 | Avadel Pharmaceuticals | AVDL | Downgrade | Neutral (Buy) |
18.56 (21.64) |
16.59% | Details | |
| 10/20/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 10/20/2025 | Alkermes | ALKS | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Incyte | INCY | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/9/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2025 | Teva Pharma | TEVA | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2025 | Exelixis | EXEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/22/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2025 | Royalty Pharma | RPRX | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/16/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 9/11/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 9/4/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2025 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 8/13/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 7/30/2025 | Exelixis | EXEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/30/2025 | Incyte | INCY | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/15/2025 | Incyte | INCY | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/14/2025 | Biogen | BIIB | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/9/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2025 | Legend Biotech Corp. | LEGN | Maintain | Buy (Buy) |
|
Details | ||
| 6/30/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2025 | Exelixis | EXEL | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/17/2025 | Biogen | BIIB | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/17/2025 | Alkermes | ALKS | Upgrade | Buy (Neutral) |
29.83 (50.45) |
69.13% | Details | |
| 6/11/2025 | Incyte | INCY | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/3/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2025 | Cytokinetics | CYTK | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/24/2025 | Coherus Biosciences | CHRS | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/11/2025 | Biogen | BIIB | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/8/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Royalty Pharma | RPRX | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/7/2025 | Jazz Pharmaceuticals | JAZZ | Upgrade | Buy (Neutral) |
136.45 (176.93) |
29.67% | Details | |
| 3/4/2025 | Alkermes | ALKS | Upgrade | Neutral (Sell) |
34.11 (29.83) |
-12.55% | Details | |
| 2/27/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 2/5/2025 | Intra-Cellular Therapies | ITCI | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/30/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Exelixis | EXEL | Maintain | Neutral (N/A) |
|
Details | ||
| 1/23/2025 | Teva Pharma | TEVA | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2025 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2024 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2024 | Intra-Cellular Therapies | ITCI | Maintain | Neutral (N/A) |
|
Details | ||
| 10/10/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2024 | Exelixis | EXEL | New Coverage | Neutral (N/A) |
27.60 (52.87) |
91.56% | Details | |
| 9/10/2024 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
35.59 (34.45) |
-3.2% | Details | |
| 9/3/2024 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2024 | Coherus Biosciences | CHRS | Downgrade | Neutral (Buy) |
1.37 (1.52) |
10.95% | Details | |
| 8/13/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Intra-Cellular Therapies | ITCI | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2024 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 6/25/2024 | Intra-Cellular Therapies | ITCI | Downgrade | Neutral (Buy) |
75.57 (131.87) |
74.5% | Details | |
| 6/3/2024 | Royalty Pharma | RPRX | Downgrade | Neutral (Buy) |
27.41 (40.41) |
47.43% | Details | |
| 5/28/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Neutral (N/A) |
|
Details | ||
| 2/21/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Alkermes | ALKS | Downgrade | Sell (Neutral) |
32.18 (50.45) |
56.77% | Details | |
| 2/6/2024 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
92.82 (237.92) |
156.32% | Details | |
| 2/6/2024 | Avadel Pharmaceuticals | AVDL | New Coverage | Buy (N/A) |
14.69 (18.56) |
26.34% | Details | |
| 2/6/2024 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Buy (N/A) |
44.79 (9.68) |
-78.39% | Details | |
| 1/24/2024 | Cytokinetics | CYTK | Downgrade | Neutral (Buy) |
84.80 (81.20) |
-4.25% | Details | |
| 11/27/2023 | Teva Pharma | TEVA | Upgrade | Buy (Neutral) |
9.46 (34.22) |
261.73% | Details | |
| 11/27/2023 | Jazz Pharmaceuticals | JAZZ | Downgrade | Neutral (Buy) |
121.72 (136.45) |
12.1% | Details | |
| 11/15/2023 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2023 | Viatris | VTRS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/17/2023 | Acadia Pharmaceuticals | ACAD | New Coverage | Buy (N/A) |
23.78 (23.36) |
-1.77% | Details | |
| 10/17/2023 | Alkermes | ALKS | New Coverage | Neutral (N/A) |
28.03 (32.18) |
14.81% | Details | |
| 10/17/2023 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
34.06 (61.83) |
81.53% | Details | |
| 9/20/2023 | Teva Pharma | TEVA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2023 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2023 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2023 | Teva Pharma | TEVA | Upgrade | Neutral (Sell) |
7.48 (34.22) |
357.49% | Details | |
| 6/30/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2023 | United Therapeutics Corp. | UTHR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/10/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Coherus Biosciences | CHRS | Upgrade | Buy (Neutral) |
6.00 (1.37) |
-77.17% | Details | |
| 3/7/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2023 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2022 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2022 | United Therapeutics Corp. | UTHR | New Coverage | Buy (N/A) |
273.72 (549.90) |
100.9% | Details | |
| 12/6/2022 | Legend Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
50.99 (29.38) |
-42.38% | Details | |
| 11/10/2022 | Viatris | VTRS | Upgrade | Neutral (Sell) |
11.10 (14.58) |
31.35% | Details | |
| 11/9/2022 | Royalty Pharma | RPRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Horizon Therapeutics | HZNP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/11/2022 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
47.23 (81.20) |
71.92% | Details | |
| 10/11/2022 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
106.84 (166.06) |
55.43% | Details | |
| 10/11/2022 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
7.00 (0.77) |
-89% | Details | |
| 9/16/2022 | Coherus Biosciences | CHRS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Horizon Therapeutics | HZNP | Downgrade | Neutral (Buy) |
66.96 (116.30) |
73.69% | Details | |
| 7/5/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2022 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
147.50 (229.85) |
55.83% | Details | |
| 6/14/2022 | Viatris | VTRS | New Coverage | Sell (N/A) |
11.20 (15.93) |
42.23% | Details | |
| 6/14/2022 | Teva Pharma | TEVA | New Coverage | Neutral (N/A) |
8.32 (34.22) |
311.3% | Details | |
| 6/14/2022 | Horizon Therapeutics | HZNP | New Coverage | Buy (N/A) |
85.42 (116.30) |
36.15% | Details | |
| 6/14/2022 | Royalty Pharma | RPRX | New Coverage | Buy (N/A) |
40.48 (54.28) |
34.09% | Details | |
| 6/14/2022 | Intra-Cellular Therapies | ITCI | New Coverage | Buy (N/A) |
53.02 (75.57) |
42.53% | Details | |
| 6/14/2022 | Coherus Biosciences | CHRS | New Coverage | Neutral (N/A) |
6.72 (6.00) |
-10.71% | Details |
